Please Wait
Applying Filters...
menu
    • menu

    Digital Content for DSSTox_CID_3037

    Client Email Product
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    DSSTox_CID_3037

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 6,257Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Qilu Pharm`s Generic Exemestane Receives Approval in US
    Qilu Pharm`s Generic Exemestane Receives Approval in US

    16 Apr 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213547

    FDA
    16 Apr 2020
    Share Share
    Mayne Pharma’s Generic Exemestane Receives Approval In US
    Mayne Pharma’s Generic Exemestane Receives Approval In US

    13 Aug 2019

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208764

    FDA
    13 Aug 2019
    Share Share
    Amneal Pharms' Generic Exemestane Receives Approval in US
    Amneal Pharms' Generic Exemestane Receives Approval in US

    31 Dec 2018

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206421

    FDA
    31 Dec 2018
    Share Share
    Zydus Pharms USA's Generic Exemestane Receives Approval in US
    Zydus Pharms USA's Generic Exemestane Receives Approval in US

    04 Oct 2018

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202602

    FDA
    04 Oct 2018
    Share Share
    Cipla’s Generic Exemestane Receives Approval In US
    Cipla’s Generic Exemestane Receives Approval In US

    01 May 2018

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210323

    FDA
    01 May 2018
    Share Share
    Cipla gets USFDA nod for generic equivalents of Vazculep, Aromasin
    Cipla gets USFDA nod for generic equivalents of Vazculep, Aromasin

    01 May 2018

    // THE HINDUBUSINESSLINE

    https://www.thehindubusinessline.com/companies/cipla-gets-usfda-nod-for-generic-equivalents-of-vazculep-aromasin/article23745542.ece

    THE HINDUBUSINESSLINE
    01 May 2018
    Share Share